Skip to main content
Premium Trial:

Request an Annual Quote

Zyomyx Raises Another $10M in Equity Financing

NEW YORK, Feb. 12 (GenomeWeb News) - Protein array company Zyomyx has raised $10 million in additional venture capital, the company said yesterday.


The financing round was led by CSFB Private Equity, which was joined by existing investors Alloy Ventures, Lilly BioVentures, Hambrecht & Quist Capital Management, Mediphase Venture Partners, and Bio One Capital.


Zyomyx plans to use the funding to expand its line of products. The company wants to launch a murine cytokine biochip in April, followed by other biochips later this year.


The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.